2024: record year for AI trials
One major way AI is set to revolutionize clinical trials is by automating patient recruitment, which is typically the most time-consuming part of a clinical trial....
One major way AI is set to revolutionize clinical trials is by automating patient recruitment, which is typically the most time-consuming part of a clinical trial....
It’s widely agreed that clinical trial participants should reflect the populations of people who will ultimately be affected by the resulting treatments....
As the use of artificial intelligence (AI) has greatly accelerated in recent years, AI has been moving to reshape the clinical trial landscape by addressing critical challenges and improving outcomes across the entire process....
While much of the public discourse around AI focuses on its theoretical risks or future potential, the technology already has a tangible, measurable impact on healthcare today....
Electronic methods of capture of clinical endpoint data are becoming increasingly dominant, and yet it’s notable that in some respects the industry continues to critique electronic methods in a way paper-based methods are not....
Mass General Brigham, Emory and other providers, including the UW–Madison School of Medicine and Public Health, will assess different AI models from companies like Google, Microsoft and Amazon....
At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and discern ways to overcome sector challenges....
The Wisconsin Alumni Research Foundation (WARF) will commit $15 million over the next three years to extend the University of Wisconsin–Madison’s strength in artificial intelligence research and education by supporting the university’s Research, Innovation and Scholarly Excellence Initiative (RISE) focus on AI....
Artificial Intelligence (AI) is on the cusp of quickly becoming a large component of the healthcare industry (broadly defined), with the emergence of generative AI and sophisticated predictive models making significant inroads across various domains....
Two experts on regulatory and compliance trends weigh in on the FDA's recently issued guidance on decentralized clinical trials....